Serum and Biliary Insulin-like Growth Factor I As A Diagnostic Marker for Cholangiocarcinoma / Labib Abbas Hafez ; Supervised Eman Medhat Hassan , Mohammad Salah Abdelbary , Olfat Gamil Shaker
Material type:
- قياس نسبة معامل النمو شبيه الإنسولين (1) فى الدم والعصارة الصفراوية كتحليل تشخيصى لمرضى سرطان القنوات المرارية [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.33.M.Sc.2013.La.S (Browse shelf(Opens below)) | Not for loan | 01010110063342000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.33.M.Sc.2013.La.S (Browse shelf(Opens below)) | 63342.CD | Not for loan | 01020110063342000 |
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine
Background: Cholangiocarcinoma (CCA) is the most frequent biliary malignancy. It is difficult to diagnose owing to its anatomic location, growth patterns and lack of definite diagnostic criteria. Its cells express and secrete Insulin-like growth factor I (IGF-I). Objective: Measurement of IGF-I in bile and serum of patients with extrahepatic CCA and its evaluation as a diagnostic marker. Methods: The study is a cross sectional study including 60 patients presented to endoscopic retrograde cholangiopancreatography (ERCP) unit for extrahepatic bilairy obstruction. Patients were grouped as follows: Group A including 20 patients with extrahepatic CCA, Group B 20 patients with pancreatic cancer and Group C 20 patients with benign biliary lesions
Issued also as CD
There are no comments on this title.